SYNAGEVA BIOPHARMA CORP.
- Headquarters
- LEXINGTON, MA
- Latest Form D
- $12.5M, Mar 2011
- Total capital
- $45.9M
- Federal grants
- $3.2M
- 12 awards · 2003–2008
- Private capital raised
- $42.7M
- 2 Form D · last Mar 2011
- 187 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 34 pending · first 2015
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$12.5M
- Private capital raisedForm D · SEC · 1st filing$30.2M
- Federal grantHealth and Human S · Phase II · Enhancement of the glycosylation machinery of the hen bioreactor$370K
- Federal grantHealth and Human S · Phase I · Enhancement of the glycosylation machinery of the hen bioreactor.$93K
- Federal grantHealth and Human S · Phase II · Enhancement of the glycosylation machinery of the hen bioreactor$378K
- Federal grantHealth and Human S · Phase I · Producing humanized therapeutics in quail egg white$92K
- Federal grantHealth and Human S · Phase I · Avian transgenesis via site-directed integration$90K
Show 7 earlier federal awards
- Federal grantHealth and Human S · Phase II · Avian transgenesis via site-directed integration$337K
- Federal grantHealth and Human S · Phase II · Avian transgenesis via site-directed integration$409K
- Federal grantHealth and Human S · Phase I · Ovalbumin locus BACs for expression of biotherapeutics$81K
- Federal grantHealth and Human S · Phase II · Oviduct locus BACs for expression of bio-therapeutics$382K
- Federal grantHealth and Human S · Phase II · Oviduct locus BACs for expression of bio-therapeutics$346K
- Federal grantHealth and Human S · Phase II · Producing Humanized Therapeutics in Avian Egg White$311K
- Federal grantHealth and Human S · Phase II · Producing Humanized Therapeutics in Avian Egg White$313K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
73months
from SYNAGEVA BIOPHARMA CORP.’s first federal award to its first private round.
- First federal award · Apr 2003
- Health and Human S · $313K
- First Form D · Apr 2009
- $30.2M · 1st Form D
- Awards before first raise
- 12 awards
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- FELIX J. BAKERDirectorNamed in SEC Form D filings
- JAMES L.L. TULLISDirectorNamed in SEC Form D filings
- Lyle HohnkeDirectorNamed in SEC Form D filings
- Mark GoldbergDirectorNamed in SEC Form D filings
- Robyn SamuelsDirectorNamed in SEC Form D filings
- SANJ K. PATELExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- Srini K. AkkarajuDirectorNamed in SEC Form D filings
- Stephen K. BiggarDirectorNamed in SEC Form D filings
- Thomas MalleyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 40- GrantedMethods For Treating Lysosomal Acid Lipase Deficiency In PatientsUSPTOUS 10,166,274
- GrantedEgg White ProcessingUSPTOUS 9,938,319
- GrantedRecombinant Human Naglu Protein And Uses ThereofUSPTOUS 9,579,366
Show all 40 patent records
- Methods For Treating Lysosomal Acid Lipase Deficiency In PatientsJan 1, 2019 · US 10,166,274Granted
- Egg White ProcessingApr 10, 2018 · US 9,938,319Granted
- Recombinant Human Naglu Protein And Uses ThereofFeb 28, 2017 · US 9,579,366Granted
- NPP1 Fusion ProteinsJan 10, 2017 · US 9,540,621Granted
- Producing Therapeutic ProteinsOct 8, 2015 · Application 14675896Pending
- Tissue Specific Expression Of Antibodies In ChickensSep 29, 2015 · US 9,144,229Granted
- Truncated Lysosomal Acid LipaseApr 9, 2015 · Application 14377990Pending
- Methods For Treating Lysosomal Acid Lipase DeficiencyFeb 3, 2015 · US 8,945,542Granted
- NPP1 Fusion ProteinsJan 22, 2015 · Application 14507124Pending
- Methods For Treating Lysosomal Acid Lipase Deficiency In PatientsNov 27, 2014 · Application 14102000Pending
- Avian Derived AntibodiesNov 13, 2014 · Application 14333888Pending
- Transgenic Chickens With An Inactivated Endogenous Gene LocusOct 2, 2014 · Application 14200401Pending
- Methods For Producing Transgenic Chickens Using Long-term Cultures Of Chicken Primordial Germ Cells (pgcs)Sep 25, 2014 · Application 14200370Pending
- Production of Transgenic Avians Using Improved Retroviral VectorsSep 25, 2014 · Application 14194010Pending
- Recombinant Human Naglu Protein And Uses ThereofSep 11, 2014 · Application 14350644Pending
- Germline Transmission Of Avian Primordial Germ Cells (pgcs)Aug 21, 2014 · Application 14163576Pending
- Transgenic Aves Producing Human Polyclonal AntibodiesJun 5, 2014 · Application 13930973Pending
- Long-term Culture Of Avian Primordial Germ Cells (pgcs)May 8, 2014 · Application 14103993Pending
- Methods for Treating Lysosomal Acid Lipase DeficiencyDec 12, 2013 · Application 13967446Pending
- NPP1 Fusion ProteinsApplication PCTUS2011028233Pending
- Avian Derived AntibodiesApplication PCTUS2010001545Pending
- Avian Derived Fusion ProteinsApplication PCTUS2009057552Pending
- Glycosylation In AviansApplication PCTUS2009000058Pending
- Pharmacodynamically Enhanced Therapeutic ProteinsApplication PCTUS2008003446Pending
- Transgene Expression In AviansApplication PCTUS2007022828Pending
- Therapeutic Compositions Of Alpha-l-iduronidase And Methods Of Use ThereofApplication 62173091Pending
- Producing Therapeutic ProteinsApplication PCTUS2015023778Pending
- Methods For Treating Lysosomal Acid Lipase Deficiency In PatientsApplication 14633240Pending
- Method of Treating Tissue CalcificationApplication 62094943Pending
- Therapeutic Compositions Of Alpha-l-iduronidase And Methods Of Use ThereofApplication 62093316Pending
- Therapeutic Compositions of Iduronate-2-SulfataseApplication 62080838Pending
- Recombinant Human ADA2 And ADA2 Fusion Proteins And Methods For Treating ADA2 DeficienciesApplication 62080588Pending
- THERAPEUTIC COMPOSITIONS OF alpha-GALACTOSIDASE AApplication 62077654Pending
- Methods of Treating Mucopolysaccharidosis IIIB (MPSIIIB)Application 62057030Pending
- Egg White ProcessingApplication 61983003Pending
- Producing Therapeutic ProteinsApplication 61974242Pending
- Truncated Lysosomal Acid LipaseApplication PCTUS2013028688Pending
- Recombinant Human Naglu Protein And Uses ThereofApplication PCTUS2012059708Pending
- Transgenic Birds That Produce Chimeric Human ImmunoglobulinsApplication PCTUS2012053153Pending
- Methods For Treating Lysosomal Acid Lipase DeficiencyApplication PCTUS2012025239Pending
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .